Publikationen von M. Ising
Alle Typen
Zeitschriftenartikel (290)
121.
Zeitschriftenartikel
20 (Suppl. 3), S. S427 - S428 (2010)
Polymorphisms in the BDNF gene are associated with antidepressant treatment response. European Neuropsychopharmacology 122.
Zeitschriftenartikel
15 (7), S. 736 - 747 (2010)
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Molecular Psychiatry 123.
Zeitschriftenartikel
35 (7), S. 1583 - 1592 (2010)
Gender-Specific Association of Galanin Polymorphisms with HPA-Axis Dysregulation, Symptom Severity, and Antidepressant Treatment Response. Neuropsychopharmacology 124.
Zeitschriftenartikel
67 (9 Suppl.1), S. 127S - 128S (2010)
Polymorphisms in the BDNF Gene are Associated with Antidepressant Treatment Response. Biological Psychiatry 125.
Zeitschriftenartikel
67 (9 Suppl.1), S. 128S - 128S (2010)
Fine-Mapping of Genetic Loci Linked to REM-Density in the Munich Vulnerability Study. Biological Psychiatry 126.
Zeitschriftenartikel
42 (5), S. 436 - 440 (2010)
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics 127.
Zeitschriftenartikel
20 (Suppl. 1), S. S85 - S86 (2010)
Somatisation in major depression, genetic association and clinical features. European Neuropsychopharmacology 128.
Zeitschriftenartikel
118 (2), S. 98 - 100 (2010)
Glucose Tolerance in Depressed Inpatients, under Treatment with Mirtazapine and in Healthy Controls. Experimental and Clinical Endocrinology & Diabetes 129.
Zeitschriftenartikel
35 (3), S. 727 - 740 (2010)
Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment. Neuropsychopharmacology 130.
Zeitschriftenartikel
61, S. 81 - 109 (2010)
Stress Hormone Regulation: Biological Role and Translation into Therapy. Annual Review of Psychology 131.
Zeitschriftenartikel
20 (1), S. 65 - 68 (2010)
HTR2A gene variation is involved in antidepressant treatment response. European Neuropsychopharmacology 132.
Zeitschriftenartikel
150B (8), S. 1100 - 1109 (2009)
Polymorphisms in the GAD2 Gene-Region Are Associated With Susceptibility for Unipolar Depression and With a Risk Factor for Anxiety Disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 133.
Zeitschriftenartikel
117 (10), S. 660 - 660 (2009)
Predictors of neuropsychiatric side effects and therapy response of dopamine agonist therapy in patients with prolactinomas: a clinical study concept. Experimental and Clinical Endocrinology & Diabetes 134.
Zeitschriftenartikel
73, S. 665 - 666 (2009)
Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors. Annals of Human Genetics 135.
Zeitschriftenartikel
71 (5), S. 691 - 701 (2009)
Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clinical Endocrinology 136.
Zeitschriftenartikel
66 (7), S. 708 - 711 (2009)
Gene Expression Patterns Associated with Posttraumatic Stress Disorder Following Exposure to the World Trade Center Attacks. Biological Psychiatry 137.
Zeitschriftenartikel
42 (5), S. 213 - 213 (2009)
Polymorphisms in the serotonin receptor 2A gene (HTR2A), parenting styles and the risk of depression in young adulthood: results from a family study. Pharmacopsychiatry 138.
Zeitschriftenartikel
42 (5), S. 221 - 221 (2009)
Polymorphisms of the dopamine beta-hydroxylase (DBH) gene show associations with cognitive flexibility in mentally healthy adults. Pharmacopsychiatry 139.
Zeitschriftenartikel
42 (5), S. 222 - 222 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature project. Pharmacopsychiatry 140.
Zeitschriftenartikel
66 (9), S. 966 - 975 (2009)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry